Management Team

CEO is Dr George Butler, who is well known as a Regulatory Affairs leader in the Pharma Industry and has led Global Regulatory Affairs groups, most recently AstraZeneca and Novartis, is based in USA. Dr Melvyn Teillol-Foo, who established global bridging activities and supported regulatory in Asia with SmithKline Beecham, Pharmacia and Daiichi Pharmaceutical Company leads the Asia-Pacific group based in Singapore. Dr Debbie Scholey FTOPRA, who has 25 years of regulatory affairs experience leading Regulatory Affairs groups in both small and medium sized companies and is based in the UK.

Capabilities managed by a combination of:

• In house expertise
• Alliance partners
• Flexible wide range of resources